Eli Lilly Chief Says He Will Fight for the FDA, Challenging RFK Jr.’s Stance

The New York Times – Business:

The health care giant’s David Ricks defended the agency’s role in reviewing data and ensuring drug safety.

This post first appeared in The New York Times – Business. Read the original article.